GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Ending Cash Position

Newron Pharmaceuticals SpA (XTER:NP5) Ending Cash Position : €7.90 Mil (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Ending Cash Position?

Newron Pharmaceuticals SpA's Ending Cash Position for the quarter that ended in Jun. 2024 was €7.90 Mil.

Newron Pharmaceuticals SpA's quarterly Ending Cash Position declined from Jun. 2023 (€7.71 Mil) to Dec. 2023 (€6.34 Mil) but then increased from Dec. 2023 (€6.34 Mil) to Jun. 2024 (€7.90 Mil).

Newron Pharmaceuticals SpA's annual Ending Cash Position declined from Dec. 2021 (€25.02 Mil) to Dec. 2022 (€13.42 Mil) and declined from Dec. 2022 (€13.42 Mil) to Dec. 2023 (€6.34 Mil).


Newron Pharmaceuticals SpA Ending Cash Position Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Ending Cash Position Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.05 13.21 25.02 13.42 6.34

Newron Pharmaceuticals SpA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.88 13.42 7.71 6.34 7.90

Newron Pharmaceuticals SpA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Newron Pharmaceuticals SpA's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=13.424+-7.086
=6.34

Newron Pharmaceuticals SpA's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6.338+1.559
=7.90


Newron Pharmaceuticals SpA Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Stefan Weber Board of Directors
Dr. Ulrich Köstlin Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines